ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Published online before print April 12, 2006
Eur Respir J 2006, doi:10.1183/09031936.06.00124605
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
28/3/523    most recent
09031936.06.00124605v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halbert, R.J.
Right arrow Articles by Mannino, D.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halbert, R.J.
Right arrow Articles by Mannino, D.M.

ORIGINAL ARTICLE

Global burden of COPD: systematic review and meta-analysis

R.J. Halbert 1*, J.L. Natoli 2, Anacleto Gano 3, E. Badamgarav 3, A.S. Buist 4, D.M. Mannino 5

1 Cerner Health Insights, Beverly Hills, CA and Dept of Community Health Sciences, UCLA School of Public Health, Los Angeles, CA
2 Cerner Health Insights, Beverly Hills, CA and Dept of Epidemiology, UCLA School of Public Health, Los Angeles, CA
3 Cerner Health Insights, Beverly Hills, CA
4 Dept of Pulmonary and Critical Care Medicine, Oregon Health and Science University
5 Dept of Pulmonary and Critical Care Medicine, University of Kentucky, Lexington, KY

* To whom correspondence should be addressed. E-mail: rhalbert{at}cerner.com.


  Abstract

To quantify the global prevalence of chronic obstructive pulmonary disease (COPD), we conducted a systematic review and random effects meta-analysis.

We searched MEDLINE for population-based prevalence estimates published from 1990-2004. Articles were included if they (1) provided total population or gender-specific estimates for COPD, chronic bronchitis (CB), and/or emphysema; and (2) had methods sufficiently clear to establish the sampling strategy, approach to diagnosis, and diagnostic criteria.

Of 67 accepted articles, 62 unique entries yielded 100 overall prevalence estimates from 28 different counties. The pooled prevalence for COPD was 7.5% (95% CI: 6.0%-9.2%) from 37 studies, 6.4% (5.3%-7.7%) for CB alone (38 studies), and 1.8% (1.3%-2.6%) for emphysema alone (8 studies). Pooled prevalence from 26 spirometric estimates was 8.9% (7.4%-10.7%). The most common spirometric definitions were those of the Global Initiative for Obstructive Lung Disease (GOLD, 12 estimates). There was statistically significant heterogeneity that was incompletely explained by subgroup analysis (eg, age, smoking status).

The prevalence of physiologically defined COPD in adults aged 40 years and older is approximately 9%-10%. There are important regional gaps, and methodological differences hinder interpretation of available data. The efforts of GOLD and similar groups should help standardize COPD prevalence measurement.

Keywords:  Chronic bronchitis, chronic obstructive pulmonary disease, emphysema, meta-analysis, prevalence, spirometry




This article has been cited by other articles:


Home page
 AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
R. Mann and J. Nichols
Management of Chronic Obstructive Pulmonary Disease
American Journal of Lifestyle Medicine, November 1, 2009; 3(6): 458 - 465.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
M. Rutten-van Molken
Raising the awareness: projecting the future burden of COPD with the BOLD model
Eur. Respir. J., October 1, 2009; 34(4): 787 - 789.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
W. M. Vollmer, Th. Gislason, P. Burney, P. L. Enright, A. Gulsvik, A. Kocabas, and A. S. Buist
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study
Eur. Respir. J., September 1, 2009; 34(3): 588 - 597.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. Janda, K. Park, J. M. FitzGerald, M. Etminan, and J. Swiston
Statins in COPD: A Systematic Review
Chest, September 1, 2009; 136(3): 734 - 743.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. M. de Oca, C. Talamo, R. J. Halbert, R. Perez-Padilla, M. V. Lopez, A. Muino, J. R. B. Jardim, G. Valdivia, J. Pertuze, D. Moreno, et al.
Frequency of Self-Reported COPD Exacerbation and Airflow Obstruction in Five Latin American Cities: The Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) Study
Chest, July 1, 2009; 136(1): 71 - 78.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Marin-Corral, J. Minguella, A. L. Ramirez-Sarmiento, S. N. A. Hussain, J. Gea, and E. Barreiro
Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients
Eur. Respir. J., June 1, 2009; 33(6): 1309 - 1319.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
S. J. Moghaddam, H. Li, S.-N. Cho, M. K. Dishop, I. I. Wistuba, L. Ji, J. M. Kurie, B. F. Dickey, and F. J. DeMayo
Promotion of Lung Carcinogenesis by Chronic Obstructive Pulmonary Disease-Like Airway Inflammation in a K-ras-Induced Mouse Model
Am. J. Respir. Cell Mol. Biol., April 1, 2009; 40(4): 443 - 453.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
N. M. Hawkins, Z. Huang, K. S. Pieper, S. D. Solomon, L. Kober, E. J. Velazquez, K. Swedberg, M. A. Pfeffer, J. J.V. McMurray, A. P. Maggioni, et al.
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
Eur J Heart Fail, March 1, 2009; 11(3): 292 - 298.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. S. Buist
Introduction.
Proceedings of the ATS, December 1, 2008; 5(8): 796 - 799.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. F. P. Man, L. Xing, J. E. Connett, N. R. Anthonisen, R. A. Wise, D. P. Tashkin, X. Zhang, R. Vessey, T. G. Walker, B. R. Celli, et al.
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?
Eur. Respir. J., December 1, 2008; 32(6): 1451 - 1457.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. M. Kunisaki and D. E. Niewoehner
Antibiotic Prophylaxis for Chronic Obstructive Pulmonary Disease: Resurrecting an Old Idea
Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1098 - 1099.
[Full Text] [PDF]

Home page
 Infect. Immun.Home page
B. Pang, W. Hong, S. L. West-Barnette, N. D. Kock, and W. E. Swords
Diminished ICAM-1 Expression and Impaired Pulmonary Clearance of Nontypeable Haemophilus influenzae in a Mouse Model of Chronic Obstructive Pulmonary Disease/Emphysema
Infect. Immun., November 1, 2008; 76(11): 4959 - 4967.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P-O Bridevaux, M W Gerbase, N M Probst-Hensch, C Schindler, J-M Gaspoz, and T Rochat
Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD
Thorax, September 1, 2008; 63(9): 768 - 774.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
Z. E. K. Pogson, T. M. McKeever, and A. Fogarty
The association between serum osmolality and lung function among adults
Eur. Respir. J., July 1, 2008; 32(1): 98 - 104.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. L. Wright, M. Cosio, and A. Churg
Animal models of chronic obstructive pulmonary disease
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L1 - L15.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
N. Roche, F. Dalmay, T. Perez, C. Kuntz, A. Vergnenegre, F. Neukirch, J-P. Giordanella, and G. Huchon
Impact of chronic airflow obstruction in a working population
Eur. Respir. J., June 1, 2008; 31(6): 1227 - 1233.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
O. A. Minai, J. Benditt, and F. J. Martinez
Natural History of Emphysema
Proceedings of the ATS, May 1, 2008; 5(4): 468 - 474.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M Bednarek, J Maciejewski, M Wozniak, P Kuca, and J Zielinski
Prevalence, severity and underdiagnosis of COPD in the primary care setting
Thorax, May 1, 2008; 63(5): 402 - 407.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Churg, M. Cosio, and J. L. Wright
Mechanisms of cigarette smoke-induced COPD: insights from animal models
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L612 - L631.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Medicherla, M. F. Fitzgerald, D. Spicer, P. Woodman, J. Y. Ma, A. M. Kapoun, S. Chakravarty, S. Dugar, A. A. Protter, and L. S. Higgins
p38{alpha}-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 921 - 929.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. Hallberg, A. Dominicus, U. K. Eriksson, M. Gerhardsson de Verdier, N. L. Pedersen, M. Dahlback, U. Nihlen, T. Higenbottam, and M. Svartengren
Interaction between Smoking and Genetic Factors in the Development of Chronic Bronchitis
Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 486 - 490.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. C. Tan and T. P. Ng
COPD in Asia*: Where East Meets West
Chest, February 1, 2008; 133(2): 517 - 527.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
C.J.P. Smith, J. Gribbin, K.B. Challen, and R.B. Hubbard
The impact of the 2004 NICE guideline and 2003 General Medical Services contract on COPD in primary care in the UK
QJM, February 1, 2008; 101(2): 145 - 153.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. K. Han, D. Postma, D. M. Mannino, N. D. Giardino, S. Buist, J. L. Curtis, and F. J. Martinez
Gender and Chronic Obstructive Pulmonary Disease: Why It Matters
Am. J. Respir. Crit. Care Med., December 15, 2007; 176(12): 1179 - 1184.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi
Definition, epidemiology and natural history of COPD
Eur. Respir. J., November 1, 2007; 30(5): 993 - 1013.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. D. Sin and W. C. Tan
Breaking Down the "Great Wall" of COPD Care in China
Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 732 - 733.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. Zhong, C. Wang, W. Yao, P. Chen, J. Kang, S. Huang, B. Chen, C. Wang, D. Ni, Y. Zhou, et al.
Prevalence of Chronic Obstructive Pulmonary Disease in China: A Large, Population-based Survey
Am. J. Respir. Crit. Care Med., October 15, 2007; 176(8): 753 - 760.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
D. M. Mannino and S. Braman
The Epidemiology and Economics of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, October 1, 2007; 4(7): 502 - 506.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. F. Rabe, S. Hurd, A. Anzueto, P. J. Barnes, S. A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, et al.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary
Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 532 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Shirtcliffe, M. Weatherall, S. Marsh, J. Travers, A. Hansell, A. McNaughton, S. Aldington, H. Muellerova, and R. Beasley
COPD prevalence in a random population survey: a matter of definition
Eur. Respir. J., August 1, 2007; 30(2): 232 - 239.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. F. Rabe, B. Beghe, F. Luppi, and L. M. Fabbri
Update in Chronic Obstructive Pulmonary Disease 2006
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1222 - 1232.
[Full Text] [PDF]

Home page
 ChestHome page
D. Stolz, M. Christ-Crain, R. Bingisser, J. Leuppi, D. Miedinger, C. Muller, P. Huber, B. Muller, and M. Tamm
Antibiotic Treatment of Exacerbations of COPD: A Randomized, Controlled Trial Comparing Procalcitonin-Guidance With Standard Therapy
Chest, January 1, 2007; 131(1): 9 - 19.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the European Respiratory Society.